Osteoporosis, Osteopenia Unknown Status Phase 3 Trials for Denosumab (DB06643)

Back to Osteoporosis, Osteopenia

Also known as: Osteoporosis or Osteopenia / Osteopenia, Osteoporosis / Osteopenia/Osteoporosis

IndicationStatusPhase
DBCOND0034537 (Osteoporosis, Osteopenia)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04034199Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic AcidTreatment